160 related articles for article (PubMed ID: 29792394)
1. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
Katsube Y; Hira D; Tsujimoto M; Koide H; Minegaki T; Ikeda Y; Morita SY; Nishiguchi K; Terada T
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):328-336. PubMed ID: 29792394
[TBL] [Abstract][Full Text] [Related]
2. Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).
Bönner G; Landers B; Bramlage P
Vasc Health Risk Manag; 2011; 7():85-95. PubMed ID: 21415922
[TBL] [Abstract][Full Text] [Related]
3. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.
Ketelhut R; Bramlage P
Clin Drug Investig; 2010; 30(5):301-11. PubMed ID: 20384386
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
6. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
7. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators.
Zuschke CA; Keys I; Munger MA; Carr AA; Marinides GN; Flanagan TL; Cushing DJ; Hayes JL; Michelson EL
Clin Ther; 1999 Mar; 21(3):464-74. PubMed ID: 10321416
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan.
Yasuno S; Fujimoto A; Nakagawa Y; Kuwahara K; Ueshima K
Expert Rev Cardiovasc Ther; 2012 May; 10(5):577-83. PubMed ID: 22651833
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
[TBL] [Abstract][Full Text] [Related]
11. Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.
Plosker GL; Keam SJ
Pharmacoeconomics; 2006; 24(12):1249-72. PubMed ID: 17129078
[TBL] [Abstract][Full Text] [Related]
12. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
Meredith PA
Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.
Jeon JY; Im YJ; Kim Y; Han SM; Jo MJ; Shin DH; Yoo JS; Moon BK; Kim BK; Lee BH; Choi YH; Cho BS; Jang HY; Chae SW; Kim MG
Drug Dev Ind Pharm; 2013 Sep; 39(9):1296-9. PubMed ID: 23030309
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
Kaku K; Enya K; Sugiura K; Totsuka N
Curr Med Res Opin; 2011 Nov; 27 Suppl 3():73-84. PubMed ID: 22106979
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.
Takahara M; Shiraiwa T; Shindo M; Arai A; Kusuda Y; Katakami N; Kaneto H; Matsuoka TA; Shimomura I
Hypertens Res; 2014 Sep; 37(9):852-7. PubMed ID: 24739538
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
Pietruck F; Kiel G; Birkel M; Stahlheber-Dilg B; Philipp T
Biopharm Drug Dispos; 2005 May; 26(4):135-41. PubMed ID: 15768377
[TBL] [Abstract][Full Text] [Related]
18. Erythema multiforme associated with candesartan cilexetil.
Ejaz AA; Walsh JS; Wasiluk A
South Med J; 2004 Jun; 97(6):614-5. PubMed ID: 15255435
[TBL] [Abstract][Full Text] [Related]
19. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
20. [Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis].
Sturm N; Hilleret MN; Dreyfus T; Barnoud D; Leroy V; Zarski JP
Gastroenterol Clin Biol; 2005 Dec; 29(12):1299-301. PubMed ID: 16518295
[No Abstract] [Full Text] [Related]
[Next] [New Search]